Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Ho, Chih Ming ^a,b,c   Chang, Shwu Fen ^c   Hsiao, Chih Chiang ^c   Chien, Tsai Yen ^a   Shih, Daniel ^c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

epithelial ovarian adenocarcinoma; epithelial mesenchymal transition; human cancer initiating stem cell; stromal progenitor cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CD133 ANTIGEN; CD146 ANTIGEN; CD24 ANTIGEN; CELL MARKER; CYTOKERATIN 18; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; REX PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VASCULOTROPIN RECEPTOR 3; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYME CELL; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STROMA CELL; TUMOR CELL; ADENOCARCINOMA; ADULT STEM CELL; CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY; TUMOR CELL CULTURE;

ADENOCARCINOMA; ADULT; ADULT STEM CELLS; AGED; AGED, 80 AND OVER; ASCITES; ASCITIC FLUID; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 84857019139     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-23     Document Type: Article

References (38)

1. Cancer in women. Pecorelli S, Favalli G, Zigliani L, Odicino F, Int J Gynaecol Obstet 2003 82 369 79 10.1016/S0020-7292(03)00225-X 14499983 (Pubitemid 37120520)
2. The biology of ovarian cancer development. Godwin AK, Testa JR, Hamilton TC, Cancer 1993 71 530 536 8420673 (Pubitemid 23021247)
3. Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Auersperg N, Ota T, Mitchell GW, Int J Gynecol Cancer 2002 12 691 703 10.1046/j.1525-1438.2002.01152.x 12445245 (Pubitemid 35388036)
4. Early events in ovarian oncogenesis. Cvetkovic D, Reprod Biol Endocrinol 2003 1 68 10.1186/1477-7827-1-68 14577833
5. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP, Gynecol Oncol 2004 93 170 181 10.1016/j.ygyno.2003.12.034 15047232 (Pubitemid 38429567)
6. Migratory neighbors and distant invaders: tumor-associated niche cells. Wels J, Kaplan RN, Rafii S, Lyden D, Genes Dev 2008 22 559 574 10.1101/gad.1636908 18316475 (Pubitemid 351342429)
7. Stromal fibroblasts in cancer initiation and progression. Bhowmick NA, Neilson EG, Moses HL, Nature 2004 432 332 337 10.1038/nature03096 15549095 (Pubitemid 39551661)
8. The hallmarks of cancer. Hanahan D, Weinberg RA, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)
9. Cancer metastasis: building a framework. Gupta GP, Massague J, Cell 2006 127 679 695 10.1016/j.cell.2006.11.001 17110329 (Pubitemid 44781029)
10. Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors. Zhang Shu, Balch Curt, Michael Chan W, Lai Hung-Cheng, Matei Daniela, Jeanne Schilder M, Pearlly Yan S, Tim Huang H-M, Kenneth Nephew P, Cancer Res 2008 68 4311 4320 10.1158/0008-5472.CAN-08-0364 18519691
11. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Bonnet D, Dick JE, Nat Med 1997 3 730 737 10.1038/nm0797-730 9212098 (Pubitemid 27298715)
12. Prospective identification of tumorigenic prostate cancer stem cells. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, Cancer Res 2005 65 10946 10951 10.1158/0008-5472.CAN-05-2018 16322242 (Pubitemid 41713363)
13. Phenotypic characterization of human colorectal cancer stem cells. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF, Proc Natl Acad Sci USA 2007 104 10158 10163 10.1073/pnas.0703478104 17548814 (Pubitemid 47175279)
14. A tumorigenic subpopulation with stem cell properties in melanomas. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M, Cancer Res 2005 65 9328 9337 10.1158/0008-5472.CAN-05-1343 16230395 (Pubitemid 41508000)
15. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T, Cell 2005 121 823 835 10.1016/j.cell.2005.03.032 15960971 (Pubitemid 40806415)
16. Identification of pancreatic cancer stem cells. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM, Cancer Res 2007 67 1030 1037 10.1158/0008-5472.CAN-06-2030 17283135
17. The epithelial-mesenchymal transition generates cells with properties of stem cells. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisket C, Yang J, Weinberg RA, Cell 2008 133 704 715 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
18. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transitions. Savagner P, BioEssays 2001 23 912 923 10.1002/bies.1132 11598958 (Pubitemid 32972691)
19. Epithelial-mesenchymal transitions in tumor progression. Thiery JP, Nat Rev Cancer 2002 2 442 454 10.1038/nrc822 12189386
20. Epithelial-mesenchymal transition and the invasive potential of tumors. Gavert Nancy, Ben-Ze'ev Avri, Trends Mol Med 2008 14 199 209 10.1016/j.molmed.2008.03.004 18406208
21. Ovarian surface epithelium: biology, endocrinology, and pathology. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC, Endocr Rev 2001 22 255 288 10.1210/er.22.2.255 11294827 (Pubitemid 32458162)
22. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B, Int J Cancer 2009 126 2090 2101
23. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP, Cancer Res 2008 68 4311 4320 10.1158/0008-5472.CAN-08-0364 18519691
24. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G, Cell Cycle 2009 8 158 166 10.4161/cc.8.1.7533 19158483
25. Prospective identification of tumorigenic breast cancer cells. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, Proc Natl Acad Sci USA 2003 100 3983 3988 10.1073/pnas.0530291100 12629218 (Pubitemid 36418143)
26. Identification of a cancer stem cell in human brain tumors. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB, Cancer Res 2003 63 5821 5828 14522905 (Pubitemid 37187480)
27. CD44 s and CD44v6 expression in head and neck epithelia. Mack B, Gires O, PLoS ONE 2008 3 3360 3369 10.1371/journal.pone.0003360
28. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK, Oncogene 2009 28 209 218 10.1038/onc.2008.374 18836486
29. Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: A novel in vitro tumor model. Walter-Yohrling J, Pratt BM, Ledbetter S, Teicher BA, Cancer Chemother Pharmacol 2003 52 263 269 10.1007/s00280-003-0664-2 12879277 (Pubitemid 37352591)
30. The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids. Gilead A, Meir G, Neeman M, Int J Cancer 2004 108 524 531 10.1002/ijc.11583 14696116 (Pubitemid 38036652)
31. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE, Skubitz AP, Am J Pathol 2001 159 2071 2080 10.1016/S0002-9440(10)63058-1 11733357 (Pubitemid 33104261)
32. Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Jones LM, Gardner MJ, Catterall JB, Turner JA, Clin Exp Metastasis 1995 13 373 380 7641421
33. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Burleson KM, Hansen LK, Skubitz AP, Clin Exp Metastasis 2004 21 685 697 16035613
34. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP, Gynecol Oncol 2004 93 170 181 10.1016/j.ygyno.2003.12.034 15047232 (Pubitemid 38429567)
35. Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. Sako A, Kitayama J, Yamaguchi H, Kaisaki S, Suzuki H, Fukatsu K, Fujii S, Nagawa H, J Surg Res 2003 115 113 120 10.1016/S0022-4804(03)00307-X 14572781 (Pubitemid 37323956)
36. Mesothelial cells stimulate the anchorage-independent growth of human ovarian tumour cells. Wilson A, Br J Cancer 1989 59 876 882 10.1038/bjc.1989.186 2786728 (Pubitemid 19155700)
37. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera1 L, Keller E, McCauley L, Cho K, Buckanovich1 R, J Clin Invest 2011 121 3206 3219 10.1172/JCI45273 21737876
38. Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Martinet L, Poupot R, Mirshahi P, Rafii A, Fournié JJ, Mirshahi M, Mary Poupot M, Int J Cancer 2010 126 2143 2152 19739080